Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics

NCT07553949 | Not Yet Recruiting

• 2 other identifiers: IRB25-04561R01MH140440
• Study Type: interventional
• Target: 465
• Locations: 0 countries
• Sites: N/A

Brief Summary

Long-acting injectable HIV medication is an important new innovation in HIV treatment, but complex delivery logistics have resulted in limited access for people with HIV (PWH). The goal of this study is to use clinic-based pharmacy technicians to improve delivery of long-acting injectable HIV medication at federally qualified health centers in Chicago. Participants at the community clinics may be invited to take part in study surveys or interviews. Participants at the community clinics will be part of an observational cohort.

Conditions

HIV

Keywords

HIV

Outcome Measures

Primary Outcomes (1)

• LA-CAB/RPV Initiation Rate

  Number of LA-CAB/RPV initiations per number of HIV provider visits per month

  Baseline through 42 months

Study Arms (1)

Intervention

EXPERIMENTAL

The primary intervention is the integration of a pharmacy technician into the HIV care team. In addition, several other implementation strategies will be used to support programs in effectively initiating and maintaining people living with HIV on long-acting injectable treatment, including multidisciplinary case conferences, robust relationships with the specialty pharmacies that supply LA-CAB/RPV, and tools for quality monitoring.

Other: Pharmacy-technician based model

Interventions

Pharmacy-technician based model OTHER

The pharmacy technician will be integrated into the HIV care team, taking referrals, documenting contact information for patients, assessing patient-level barriers to receipt of LA CAB/RPV (social determinants) for discussion with the care team, ensuring drug coverage, coordinating medication delivery and storage, tracking injections, scheduling injections, and completing clinical documentation.

Intervention

Eligibility Criteria

• Age: 15 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with HIV at implementation sites
• English or Spanish speaking
• Age 15 year and older
• Able to provide informed consent

You may not qualify if:

• Inability to provide informed consent due to cognitive deficits, active psychosis, or acute intoxication

Sponsors & Collaborators

• University of Chicago: lead
• National Institute of Mental Health (NIMH): collaborator
• University of California, San Francisco: collaborator
• Lawndale Christian Health Center: collaborator
• Chicago Family Health Center: collaborator

Study Officials

• Moira McNulty

  University of Chicago

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Moira McNulty

CONTACT

773-834-5528; Moira.McNulty@bsd.uchicago.edu

Samantha Devlin

CONTACT

sdevlin1@bsd.uchicago.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 14, 2026
• First Posted: April 28, 2026
• Study Start (Estimated): January 1, 2027
• Primary Completion (Estimated): January 1, 2030
• Study Completion (Estimated): May 1, 2030
• Last Updated: April 28, 2026

Record last verified: 2026-04